{"id":"https://openalex.org/W4409155159","doi":"https://doi.org/10.1093/skinhd/vzaf011","title":"Tirabrutinib-associated toxic epidermal necrolysis: a case report and review of the literature","display_name":"Tirabrutinib-associated toxic epidermal necrolysis: a case report and review of the literature","publication_year":2025,"publication_date":"2025-02-14","ids":{"openalex":"https://openalex.org/W4409155159","doi":"https://doi.org/10.1093/skinhd/vzaf011","pmid":"https://pubmed.ncbi.nlm.nih.gov/40365248"},"language":"en","primary_location":{"id":"doi:10.1093/skinhd/vzaf011","doi":"https://doi.org/10.1093/skinhd/vzaf011","is_oa":true,"landing_page_url":"https://doi.org/10.1093/skinhd/vzaf011","pdf_url":"https://academic.oup.com/skinhd/advance-article-pdf/doi/10.1093/skinhd/vzaf011/62872087/vzaf011.pdf","source":{"id":"https://openalex.org/S4210233137","display_name":"Skin Health and Disease","issn_l":"2690-442X","issn":["2690-442X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin Health and Disease","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/skinhd/advance-article-pdf/doi/10.1093/skinhd/vzaf011/62872087/vzaf011.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5116925291","display_name":"Noriko Ikegawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188700360","display_name":"University of Occupational and Environmental Health Japan","ror":"https://ror.org/020p3h829","country_code":"JP","type":"education","lineage":["https://openalex.org/I188700360"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Ikegawa","raw_affiliation_strings":["Department of Dermatology, University of Occupational and Environmental Health , Kitakyushu, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Occupational and Environmental Health , Kitakyushu, Japan","institution_ids":["https://openalex.org/I188700360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031314910","display_name":"Natsuko Saito\u2010Sasaki","orcid":"https://orcid.org/0000-0001-6122-8429","observed_orcids":["https://orcid.org/0000-0001-6122-8429"]},"institutions":[{"id":"https://openalex.org/I188700360","display_name":"University of Occupational and Environmental Health Japan","ror":"https://ror.org/020p3h829","country_code":"JP","type":"education","lineage":["https://openalex.org/I188700360"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Natsuko Saito-Sasaki","raw_affiliation_strings":["Department of Dermatology, University of Occupational and Environmental Health , Kitakyushu, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Occupational and Environmental Health , Kitakyushu, Japan","institution_ids":["https://openalex.org/I188700360"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030411871","display_name":"Yu Sawada","orcid":"https://orcid.org/0000-0001-8793-708X","observed_orcids":["https://orcid.org/0000-0001-8793-708X"]},"institutions":[{"id":"https://openalex.org/I188700360","display_name":"University of Occupational and Environmental Health Japan","ror":"https://ror.org/020p3h829","country_code":"JP","type":"education","lineage":["https://openalex.org/I188700360"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yu Sawada","raw_affiliation_strings":["Department of Dermatology, University of Occupational and Environmental Health , Kitakyushu, Japan"],"raw_orcid":"https://orcid.org/0000-0001-8793-708X","affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Occupational and Environmental Health , Kitakyushu, Japan","institution_ids":["https://openalex.org/I188700360"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030411871"],"corresponding_institution_ids":["https://openalex.org/I188700360"],"apc_list":{"value":1969,"currency":"GBP","value_usd":2597},"apc_paid":{"value":1969,"currency":"GBP","value_usd":2597},"fwci":0.4944,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.60665886,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"5","issue":"2","first_page":"151","last_page":"153"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirabrutinib","display_name":"tirabrutinib","score":1.0},{"id":"https://openalex.org/keywords/toxic-epidermal-necrolysis","display_name":"toxic epidermal necrolysis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.9670000076293945},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.6859999895095825},{"id":"https://openalex.org/keywords/drug-induced-skin-reaction","display_name":"drug-induced skin reaction","score":0.7599999904632568},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9440000057220459},{"id":"https://openalex.org/keywords/refractory-lymphoma","display_name":"refractory lymphoma","score":0.7390000224113464},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C2780664588","wikidata":"https://www.wikidata.org/wiki/Q1878682","display_name":"Toxic epidermal necrolysis","level":2,"score":0.9269099235534668},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.8165251612663269},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6655923128128052},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5757932662963867},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.536604106426239},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5202575922012329},{"id":"https://openalex.org/C2778784858","wikidata":"https://www.wikidata.org/wiki/Q1363741","display_name":"Erythroderma","level":2,"score":0.5112302303314209},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.49785661697387695},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4963691830635071},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4488711953163147},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.44643792510032654},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4221765995025635},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3949306607246399},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35023796558380127},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.31111979484558105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23310056328773499},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2054741084575653},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.1890491247177124},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1339067816734314},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.13031890988349915},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.09707856178283691},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.09666156768798828},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.058635443449020386},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/skinhd/vzaf011","doi":"https://doi.org/10.1093/skinhd/vzaf011","is_oa":true,"landing_page_url":"https://doi.org/10.1093/skinhd/vzaf011","pdf_url":"https://academic.oup.com/skinhd/advance-article-pdf/doi/10.1093/skinhd/vzaf011/62872087/vzaf011.pdf","source":{"id":"https://openalex.org/S4210233137","display_name":"Skin Health and Disease","issn_l":"2690-442X","issn":["2690-442X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin Health and Disease","raw_type":"journal-article"},{"id":"pmid:40365248","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40365248","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin health and disease","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:12068473","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12068473","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Skin Health Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/skinhd/vzaf011","doi":"https://doi.org/10.1093/skinhd/vzaf011","is_oa":true,"landing_page_url":"https://doi.org/10.1093/skinhd/vzaf011","pdf_url":"https://academic.oup.com/skinhd/advance-article-pdf/doi/10.1093/skinhd/vzaf011/62872087/vzaf011.pdf","source":{"id":"https://openalex.org/S4210233137","display_name":"Skin Health and Disease","issn_l":"2690-442X","issn":["2690-442X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin Health and Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8700000047683716,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4409155159.pdf","grobid_xml":"https://content.openalex.org/works/W4409155159.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1977880576","https://openalex.org/W1979816280","https://openalex.org/W2307604147","https://openalex.org/W2336538042","https://openalex.org/W2596088044","https://openalex.org/W2910850766","https://openalex.org/W2969802847","https://openalex.org/W3037142274","https://openalex.org/W3189601110","https://openalex.org/W4200022527"],"related_works":["https://openalex.org/W1830209188","https://openalex.org/W2990290302","https://openalex.org/W3083764575","https://openalex.org/W3133876073","https://openalex.org/W2981016883","https://openalex.org/W2512656347","https://openalex.org/W2614001962","https://openalex.org/W4249624647","https://openalex.org/W1999824748","https://openalex.org/W4223965717"],"abstract_inverted_index":{"Abstract":[0],"Tirabrutinib,":[1],"a":[2,34,37],"Bruton":[3],"tyrosine":[4],"kinase":[5],"(BTK)":[6],"inhibitor,":[7],"has":[8],"shown":[9],"efficacy":[10],"in":[11],"recurrent":[12],"or":[13],"refractory":[14,41],"diffuse":[15],"large":[16],"B-cell":[17],"lymphoma":[18],"(DLBCL).":[19],"However,":[20],"severe":[21],"drug":[22,53,98],"eruptions,":[23],"including":[24,65],"toxic":[25],"epidermal":[26],"necrolysis":[27],"(TEN),":[28],"have":[29],"been":[30],"reported.":[31],"We":[32],"present":[33],"case":[35],"of":[36,49],"74-year-old":[38],"man":[39],"with":[40,60],"DLBCL":[42],"who":[43],"developed":[44],"TEN":[45],"after":[46],"1":[47],"month":[48],"tirabrutinib":[50,57],"treatment.":[51],"Severe":[52],"eruptions":[54],"linked":[55],"to":[56,78,86],"are":[58,84],"rare,":[59],"only":[61],"three":[62],"cases":[63],"reported,":[64],"ours.":[66],"Tirabrutinib\u2019s":[67],"selective":[68],"BTK":[69,96],"inhibition":[70],"may":[71],"activate":[72],"cytotoxic":[73],"CD8+":[74],"T":[75],"cells,":[76],"contributing":[77],"Stevens\u2013Johnson":[79],"syndrome/TEN":[80],"pathogenesis.":[81],"Further":[82],"studies":[83],"needed":[85],"clarify":[87],"the":[88],"mechanisms":[89],"and":[90],"develop":[91],"better":[92],"diagnostic":[93],"approaches":[94],"for":[95],"inhibitor-related":[97],"eruptions.":[99]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-10-10T00:00:00"}